Speakers 2021

Speakers 2021

Nicolas FERRY

Servier

Scientific Director Cell and Gene Therapy


THE REGULATION OF ATMP + DIFFICULTIES AND SUCCES FOR CLINICAL TRANSFER

2nd July

Nicolas Ferry is a M.D., Ph.D. His initial training in research was in endocrinology and pharmacology where he studies the regulation alpha adrenergic receptors in liver and blood platelets. During a post-doctoral stay at the Pasteur Institute in 1990, he entered the field of cell and gene therapy. He served as a scientist at the INSERM for more than 25 years where he developed new strategies of gene and cell therapies for liver cancer and hepatic inherited diseases in Paris (Necker Hospital), Rennes and Nantes. He eventually created his own INSERM lab, in 2009. During his research career, he co-authored more than 100 scientific publications. Nicolas was a gene therapy expert for the french Affsaps from 2000 to 2010. In 2011 he joined the ANSM as head of the department of vaccines, blood products and advanced therapies. He was also member of the CAT of the EMA in London from 2011 to 2016. Nicolas spent two years at Saint Louis Hospital in Paris to develop a cell and gene therapy platform. He is now Scientific Director for cell and gene therapy at Servier laboratories.

Find also